Market Place
Sourcing Support
All News #Library
Biotech
Vaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine
20 Jun 2024 //
GLOBENEWSWIRE
Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results
27 Mar 2024 //
GLOBENEWSWIRE
Vaxxinity™s Cholesterol Vaccine Candidate Successfully Lowers LDL-C
15 Feb 2024 //
GLOBENEWSWIRE
Vaxxinity, UCF in collaboration to advance space medicine
18 Jan 2024 //
FIERCE BIOTECH
Vaxxinity Announces Publication of UB-311 Data from Ph 2a in Alzheimer`s Disease
10 Aug 2023 //
GLOBENEWSWIRE
Vaxxinity celebrates trial success in early Parkinson’s therapy
23 Jun 2023 //
CLINICAL TRIALS ARENA
Vaxxinity Announces UB-312 Successfully Met Primary Objectives of Ph1 Trial
22 Jun 2023 //
GLOBENEWSWIRE
Vaxxinity to Present at World Vaccine Congress, American Academy of Neurology
28 Mar 2023 //
GLOBENEWSWIRE
Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of VXX-401
20 Mar 2023 //
GLOBENEWSWIRE
Vaxxinity to Present at the 2023 J.P. Morgan Healthcare Conference
05 Jan 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.